Branched-Chain Amino Acids Prevent Hepatocarcinogenesis and Prolong Survival of Patients With Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 6, 2014, Pages

  Kawaguchi, Takumi ^a   Shiraishi, Koichi ^b   Ito, Toshifumi ^c   Suzuki, Kazutomo ^d   Koreeda, Chizu ^e   Ohtake, Takaaki ^f   Iwasa, Motoh ^g   Tokumoto, Yoshio ^h   Endo, Ryujin ⁱ   Kawamura, Nao hiro ^j   Shiraki, Makoto ^k   Habu, Daiki ^l   Tsuruta, Satoru ^m   Miwa, Yoshiyuki ⁿ   Kawaguchi, Atsushi ^o   Kakuma, Tatsuyuki ^o   Sakai, Hironori ^m   Kawada, Norifumi ^p   Hanai, Tatsunori ^k   Takahashi, Shin ichi ^j   Kato, Akinobu ⁱ   Onji, Morikazu ^h   Takei, Yoshiyuki ^g   Kohgo, Yutaka ^f   Seki, Toshihito ^e   Tamano, Masaya ^d   Katayama, Kazuhiro ^q   Mine, Tetsuya ^b   Sata, Michio ^a   Moriwaki, Hisataka ^k   Suzuki, Kazuyuki ⁱ   more..

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY MEDICAL CENTER   (Japan)

^f ASAHIKAWA MEDICAL COLLEGE   (Japan)

^g MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l Osaka Prefecture University   (Japan)

^m NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

ⁿ Miwa Clinic   (Japan)

^o KURUME UNIVERSITY   (Japan)

^p OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^q OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

more..

Author keywords

Hepatoma; Liver cancer; Nutrition; Treatment outcome

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BRANCHED CHAIN AMINO ACID; CREATININE; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BACTERIAL INFECTION; BITTER TASTE; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RISK; CHILD PUGH SCORE; CHOLESTEROL BLOOD LEVEL; CHRONIC LIVER FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DIARRHEA; FEMALE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; HYPOALBUMINEMIA; INSULIN BLOOD LEVEL; LIFE SUSTAINING TREATMENT; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; PROTHROMBIN TIME; RISK ASSESSMENT; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COMPLICATION; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS, BRANCHED-CHAIN; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; JAPAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84901231694     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.08.050     Document Type: Article

References (27)

1. Kawaguchi T., Izumi N., Charlton M.R., et al. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 2011, 54:1063-1070.
2. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. JNutr 2006, 136:295S-298S.
3. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010, 26:482-490.
4. Moriwaki H., Miwa Y., Tajika M., et al. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 2004, 313:405-409.
5. Hagiwara A., Nishiyama M., Ishizaki S. Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms. JCell Physiol 2012, 227:2097-2105.
6. Ichikawa K., Okabayashi T., Shima Y., et al. Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride. Mol Biol Rep 2012, 39:10803-10810.
7. Shimizu M., Kubota M., Tanaka T., et al. Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis. Int J Mol Sci 2012, 13:579-595.
8. Nishikawa H., Osaki Y., Iguchi E., et al. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation. JClin Gastroenterol 2013, 47:359-366.
9. Ichikawa K., Okabayashi T., Maeda H., et al. Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study. Surg Today 2013, 43:720-726.
10. Marchesini G., Bianchi G., Merli M., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003, 124:1792-1801.
11. Muto Y., Sato S., Watanabe A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
12. Tomiya T., Omata M., Fujiwara K. Branched-chain amino acids, hepatocyte growth factor and protein production in the liver. Hepatol Res 2004, 30S:14-18.
13. Koreeda C., Seki T., Okazaki K., et al. Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis. Hepatol Res 2011, 41:417-422.
14. Nakamura I., Ochiai K., Imai Y., et al. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res 2007, 37:1062-1067.
15. Kakazu E., Ueno Y., Kondo Y., et al. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells exvivo in patients with advanced cirrhosis. Hepatology 2009, 50:1936-1945.
16. Fernandez J., Gustot T. Management of bacterial infections in cirrhosis. JHepatol 2012, 56(Suppl 1):S1-S12.
17. Charlton M. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?. Nat Clin Pract Gastroenterol Hepatol 2006, 3:72-73.
18. Wai C.T., Greenson J.K., Fontana R.J., et al. Asimple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
19. Faller B., Beuscart J.B., Frimat L. Competing-risk analysis of death and dialysis initiation among elderly (≥80 years) newly referred to nephrologists: a French prospective study. BMC Nephrol 2013, 14:103.
20. Scrucca L., Santucci A., Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007, 40:381-387.
21. Iwasa J., Shimizu M., Shiraki M., et al. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci 2010, 101:460-467.
22. Muto Y., Sato S., Watanabe A., et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006, 35:204-214.
23. Arvaniti V., D'Amico G., Fede G., et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010, 139:1246-1256.
24. Shirabe K., Yoshimatsu M., Motomura T., et al. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl 2011, 17:1073-1080.
25. Nakamura I., Ochiai K., Imawari M. Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids. Hepatol Res 2004, 29:207-211.
26. Yamada S., Kawaguchi A., Kawaguchi T., et al. Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: a data-mining analysis. Hepatol Res 2013 Jul 2, Epub ahead of print.
27. Suzuki K., Koizumi K., Ichimura H., et al. Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 2008, 38:267-272.